Pol Giménez‐Xavier

985 total citations
16 papers, 344 citations indexed

About

Pol Giménez‐Xavier is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pol Giménez‐Xavier has authored 16 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cell Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pol Giménez‐Xavier's work include melanin and skin pigmentation (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Nerve injury and regeneration (3 papers). Pol Giménez‐Xavier is often cited by papers focused on melanin and skin pigmentation (4 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Nerve injury and regeneration (3 papers). Pol Giménez‐Xavier collaborates with scholars based in Spain, United States and Germany. Pol Giménez‐Xavier's co-authors include Santiago Ambrosio, Cristina Gómez-Santos, Ricardo Pérez‐Tomás, Vanessa Soto‐Cerrato, Pepita Gimenez‐Bonafé, Gonzalo Goméz-López, David G. Pisano, Montse Sánchez‐Céspedes, Isidró Ferrer and Esther Dalfó and has published in prestigious journals such as International Journal of Cancer, European Journal of Pharmacology and Neuroreport.

In The Last Decade

Pol Giménez‐Xavier

16 papers receiving 336 citations

Peers

Countries citing papers authored by Pol Giménez‐Xavier

Since Specialization

Citations

This map shows the geographic impact of Pol Giménez‐Xavier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pol Giménez‐Xavier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pol Giménez‐Xavier more than expected).

Fields of papers citing papers by Pol Giménez‐Xavier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pol Giménez‐Xavier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pol Giménez‐Xavier. The network helps show where Pol Giménez‐Xavier may publish in the future.

Co-authorship network of co-authors of Pol Giménez‐Xavier

This figure shows the co-authorship network connecting the top 25 collaborators of Pol Giménez‐Xavier. A scholar is included among the top collaborators of Pol Giménez‐Xavier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pol Giménez‐Xavier. Pol Giménez‐Xavier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	DNA Repair and Immune Response Pathways Are Deregulated in Melanocyte-Keratinocyte Co-cultures Derived From the Healthy Skin of Familial Melanoma Patients 2021 ·Frontiers in Medicine ·Míriam Potrony, (unknown), Gemma Tell‐Martí, Pol Giménez‐Xavier, Carlos León, Marta Pevida, J. Mateu, Célia Bádenas, Cristina Carrera, Josep Malvehy, Paula Aguilera, Sara Llames, M.J. Escámez, Joan Anton Puig‐Butillé, Marcela Del Río, Susana Puig	1
2	Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11q 2018 ·European Journal of Human Genetics ·Míriam Potrony, Joan Anton Puig‐Butillé, James M. Farnham, Pol Giménez‐Xavier, Célia Bádenas, Gemma Tell‐Martí, Paula Aguilera, Cristina Carrera, Josep Malvehy, Craig C. Teerlink, Susana Puig	3
3	Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells 2018 ·Oncotarget ·Pol Giménez‐Xavier, Eva Pros, (unknown), Sebastián Morán, Raúl Tonda, Anna Esteve‐Codina, Marc Dabad, Montse Sánchez‐Céspedes	7
4	Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells 2017 ·Molecular Cancer Therapeutics ·Pol Giménez‐Xavier, Eva Pros, (unknown), Sebastián Morán, (unknown), Osvaldo Graña‐Castro, Gonzalo Goméz-López, Sophia Derdak, Marc Dabad, Anna Esteve‐Codina, José Ramón Hernández Mora, (unknown), Manel Esteller, David G. Pisano, Montse Sánchez‐Céspedes	24
5	Melanocortin 1 receptor (MC1R) polymorphisms’ influence on size and dermoscopic features of nevi 2017 ·Pigment Cell & Melanoma Research ·(unknown), Gemma Tell‐Martí, Míriam Potrony, (unknown), Célia Bádenas, Joan Anton Puig‐Butillé, Pol Giménez‐Xavier, Cristina Carrera, Josep Malvehy, Susana Puig	17
6	IRF4 rs12203592 functional variant and melanoma survival 2017 ·International Journal of Cancer ·Míriam Potrony, (unknown), Pol Giménez‐Xavier, Lisa Zimmer, Joan Anton Puig‐Butillé, Gemma Tell‐Martí, Antje Sucker, Célia Bádenas, Cristina Carrera, Josep Malvehy, Dirk Schadendorf, Susana Puig	9
7	Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis 2016 ·Oncotarget ·Joan Anton Puig‐Butillé, Pol Giménez‐Xavier, Alessia Visconti, Jérémie Nsengimana, Francisco García‐García, Gemma Tell‐Martí, M.J. Escámez, Julia Newton‐Bishop, Véronique Bataille, Marcela Del Río, Joaquı́n Dopazo, Mario Falchi, Susana Puig	6
8	The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington’s Disease Patients 2016 ·Molecular Neurobiology ·Gemma Tell‐Martí, Joan Anton Puig‐Butillé, Pol Giménez‐Xavier, (unknown), Míriam Potrony, Célia Bádenas, Victoria Álvarez, José M. Millán, María José Trujillo-Tiebas, María A. Ramos‐Arroyo, Montserrat Milà, Susana Puig	2
9	Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival 2016 ·International Journal of Cancer ·Míriam Potrony, Esther Carreras, Fernando Aranda, Lisa Zimmer, (unknown), Gemma Tell‐Martí, (unknown), Antje Sucker, Pol Giménez‐Xavier, Mario Martínez‐Florensa, Cristina Carrera, Josep Malvehy, Dirk Schadendorf, Susana Puig, Francisco Lozano	12
10	The tumour suppressor and chromatin‐remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer 2012 ·EMBO Molecular Medicine ·Octavio A. Romero, Fernando Setién, Sam John, Pol Giménez‐Xavier, Gonzalo Goméz-López, David G. Pisano, Enric Condom, Alberto Villanueva, Gordon L. Hager, Montse Sánchez‐Céspedes	70
11	Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model 2009 ·NeuroToxicology ·Pol Giménez‐Xavier, (unknown), Antonio F. Santidrián, Joan Gil, Santiago Ambrosio	37
12	Mechanisms of prodigiosin cytotoxicity in human neuroblastoma cell lines 2007 ·European Journal of Pharmacology ·(unknown), Ricardo Pérez‐Tomás, Pepita Gimenez‐Bonafé, Vanessa Soto‐Cerrato, Pol Giménez‐Xavier, Santiago Ambrosio	71
13	Dopamine induces TNFα and TNF-R1 expression in SH-SY5Y human neuroblastoma cells 2007 ·Neuroreport ·Cristina Gómez-Santos, (unknown), Pol Giménez‐Xavier, Santiago Ambrosio	15
14	Intranigral Dopamine Toxicity and α-Synuclein Response in Rats 2006 ·Neurochemical Research ·Cristina Gómez-Santos, Pol Giménez‐Xavier, Isidró Ferrer, Santiago Ambrosio	6
15	The decrease of NAD(P)H has a prominent role in dopamine toxicity 2006 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Pol Giménez‐Xavier, Cristina Gómez-Santos, Esther Castaño, (unknown), Jordi Boada, Mercedes Unzeta, Elisenda Sanz, Santiago Ambrosio	17
16	Induction of C/EBPβ and GADD153 expression by dopamine in human neuroblastoma cells 2004 ·Brain Research Bulletin ·Cristina Gómez-Santos, Marta Barrachina, Pol Giménez‐Xavier, Esther Dalfó, Isidró Ferrer, Santiago Ambrosio	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact